These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8059229)
1. Syndromes of hypercoagulability and thrombosis: a review. Bick RL; Pegram M Semin Thromb Hemost; 1994; 20(1):109-32. PubMed ID: 8059229 [TBL] [Abstract][Full Text] [Related]
2. Blood protein defects associated with thrombosis. Laboratory assessment. Bick RL; Ancypa D Clin Lab Med; 1995 Mar; 15(1):125-63. PubMed ID: 7781275 [TBL] [Abstract][Full Text] [Related]
3. Hypercoagulability and thrombosis. Bick RL Med Clin North Am; 1994 May; 78(3):635-65. PubMed ID: 8170263 [TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability and thrombosis. Bick RL; Ucar K Hematol Oncol Clin North Am; 1992 Dec; 6(6):1421-31. PubMed ID: 1452521 [TBL] [Abstract][Full Text] [Related]
5. Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis. Bick RL; Kaplan H Med Clin North Am; 1998 May; 82(3):409-58. PubMed ID: 9646773 [TBL] [Abstract][Full Text] [Related]
7. [Molecular defects of coagulation factors and of the fibrinolytic system associated with thromboembolism]. Verstraete M; Vermylen J J Mal Vasc; 1987; 12(1):3-13. PubMed ID: 3549955 [TBL] [Abstract][Full Text] [Related]
8. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis]. Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836 [TBL] [Abstract][Full Text] [Related]
9. Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects. Bick RL Hematol Oncol Clin North Am; 2003 Feb; 17(1):9-36. PubMed ID: 12627661 [TBL] [Abstract][Full Text] [Related]
10. Haematologic disorders and cerebral venous thrombosis. Akhtar N; Deleu D; Kamran S J Pak Med Assoc; 2006 Nov; 56(11):498-501. PubMed ID: 17183975 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of coagulation disorders]. Esnaola-Rojas MM Rev Neurol; 1999 Dec 16-31; 29(12):1290-300. PubMed ID: 10652759 [TBL] [Abstract][Full Text] [Related]
13. Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis. Conard J; Horellou MH; Samama M Acta Chir Scand Suppl; 1988; 543():15-25. PubMed ID: 2973199 [No Abstract] [Full Text] [Related]
14. The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates. Bick RL; Ancypa D Clin Lab Med; 1995 Mar; 15(1):63-84. PubMed ID: 7781279 [TBL] [Abstract][Full Text] [Related]
15. Recurrent venous thrombosis and hypercoagulable states. Bolan CD; Alving BM Am Fam Physician; 1991 Nov; 44(5):1741-51. PubMed ID: 1835274 [TBL] [Abstract][Full Text] [Related]
16. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction. Gram J Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835 [TBL] [Abstract][Full Text] [Related]
17. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Zöller B; García de Frutos P; Dahlbäck B Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196 [TBL] [Abstract][Full Text] [Related]
18. [Natural anticoagulants as a cause of hereditary familial thrombosis]. Tripodi A; Mannucci PM Haematologica; 1990; 75 Suppl 2():1-5. PubMed ID: 2143743 [No Abstract] [Full Text] [Related]
19. Laboratory investigation of hypercoagulability. Francis JL Semin Thromb Hemost; 1998; 24(2):111-26. PubMed ID: 9579632 [TBL] [Abstract][Full Text] [Related]